14-day Premium Trial Subscription Try For FreeTry Free
$3.95
+0.180 (+4.77%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Feb 15, 2025 Buy 120 000 Jordan Erica Performance Stock Units
Feb 15, 2025 Buy 120 000 Hollander David Performance Stock Units
May 01, 2024 Buy 15 000 Ware Olivia C Common Stock
May 01, 2024 Buy 23 458 Ware Olivia C Stock Option (Right to buy)
May 01, 2024 Buy 15 000 Russell Angus C. Common Stock
May 01, 2024 Buy 23 458 Russell Angus C. Stock Option (Right to buy)
May 01, 2024 Buy 15 000 Nolet Chris Common Stock
May 01, 2024 Buy 23 458 Nolet Chris Stock Option (Right to buy)
May 01, 2024 Buy 15 000 Kolaja Carey Oconnor Common Stock
May 01, 2024 Buy 23 458 Kolaja Carey Oconnor Stock Option (Right to buy)
May 01, 2024 Buy 15 000 Gangolli Julian S Common Stock
May 01, 2024 Buy 23 458 Gangolli Julian S Stock Option (Right to buy)
May 01, 2024 Buy 23 458 Coric Vlad Stock Option (Right to buy)
May 01, 2024 Buy 15 000 Coric Vlad Common Stock
May 01, 2024 Buy 15 000 Beraud Jill Common Stock
May 01, 2024 Buy 23 458 Beraud Jill Stock Option (Right to buy)
Apr 16, 2024 Sell 2 392 Jordan Erica Common Stock
Mar 18, 2024 Sell 9 211 Sjuts Dustin S Common Stock
Mar 18, 2024 Sell 8 125 Moxie Dwight Common Stock
Mar 18, 2024 Sell 9 361 Schilke Tobin Common Stock
Mar 15, 2024 Sell 2 967 Sjuts Dustin S Common Stock
Mar 15, 2024 Sell 3 269 Moxie Dwight Common Stock
Mar 15, 2024 Sell 3 822 Schilke Tobin Common Stock
Mar 15, 2024 Sell 3 305 Foley Mark J Common Stock
Mar 15, 2024 Sell 17 228 Foley Mark J Common Stock
Mar 06, 2024 Buy 30 000 Foley Mark J Common Stock
Feb 29, 2024 Buy 22 110 Sjuts Dustin S Common Stock
Feb 29, 2024 Buy 15 143 Moxie Dwight Common Stock
Feb 29, 2024 Buy 17 447 Schilke Tobin Common Stock
Feb 29, 2024 Buy 70 750 Foley Mark J Common Stock
Feb 27, 2024 Buy 0 Jordan Erica Common Stock
Feb 27, 2024 Buy 0 Hollander David Common Stock
Feb 27, 2024 Buy 49 669 Hollander David Stock Option (Right to buy)
Jan 31, 2024 Buy 135 000 Moxie Dwight Performance Stock Units
Jan 31, 2024 Buy 90 000 Moxie Dwight Common Stock
Jan 31, 2024 Buy 96 667 Schilke Tobin Common Stock
Jan 31, 2024 Buy 145 001 Schilke Tobin Performance Stock Units
Jan 31, 2024 Buy 1 070 001 Foley Mark J Performance Stock Units
Dec 31, 2023 Buy 264 Sjuts Dustin S Common Stock
Dec 31, 2023 Buy 434 Schilke Tobin Common Stock
Dec 31, 2023 Buy 264 Foley Mark J Common Stock
Dec 15, 2023 Sell 4 712 Sjuts Dustin S Common Stock
Sep 06, 2023 Sell 11 000 Moxie Dwight Common Stock
Sep 05, 2023 Sell 23 853 Moxie Dwight Common Stock
Aug 11, 2023 Buy 22 620 Schilke Tobin Common Stock
Aug 11, 2023 Sell 11 215 Schilke Tobin Common Stock
Aug 11, 2023 Buy 19 346 Moxie Dwight Common Stock
Aug 11, 2023 Sell 9 592 Moxie Dwight Common Stock
Aug 11, 2023 Buy 22 620 Sjuts Dustin S Common Stock
Aug 11, 2023 Sell 8 901 Sjuts Dustin S Common Stock
Aug 11, 2023 Buy 122 143 Foley Mark J Common Stock
Aug 11, 2023 Sell 48 064 Foley Mark J Common Stock
Aug 03, 2023 Sell 26 279 Foley Mark J Common Stock
Jul 03, 2023 Sell 1 701 Schilke Tobin Common Stock
Jul 03, 2023 Sell 26 279 Foley Mark J Common Stock
Jun 30, 2023 Buy 769 Schilke Tobin Common Stock
Jun 30, 2023 Buy 1 000 Sjuts Dustin S Common Stock
Jun 30, 2023 Buy 1 000 Foley Mark J Common Stock
Jun 15, 2023 Buy 2 500 Kolaja Carey Oconnor Common Stock
Jun 15, 2023 Sell 2 500 Kolaja Carey Oconnor Common Stock
Jun 15, 2023 Sell 2 500 Kolaja Carey Oconnor Stock Option (Right to buy)
Jun 09, 2023 Sell 5 000 Sjuts Dustin S Common Stock
Jun 09, 2023 Sell 31 279 Foley Mark J Common Stock
Jun 02, 2023 Sell 500 Schilke Tobin Common Stock
Jun 01, 2023 Sell 2 701 Schilke Tobin Common Stock
May 15, 2023 Sell 21 401 Moxie Dwight Common Stock
May 15, 2023 Sell 21 401 Schilke Tobin Common Stock
May 15, 2023 Sell 70 447 Foley Mark J Common Stock
May 15, 2023 Sell 21 015 Sjuts Dustin S Common Stock
May 03, 2023 Buy 3 534 Gangolli Julian S Common Stock
May 03, 2023 Buy 5 915 Gangolli Julian S Stock Option (Right to buy)
May 03, 2023 Buy 3 534 Ware Olivia C Common Stock
May 03, 2023 Buy 5 915 Ware Olivia C Stock Option (Right to buy)
May 03, 2023 Buy 3 534 Nolet Chris Common Stock
May 03, 2023 Buy 5 915 Nolet Chris Stock Option (Right to buy)
May 03, 2023 Buy 3 534 Kolaja Carey Oconnor Common Stock
May 03, 2023 Buy 5 915 Kolaja Carey Oconnor Stock Option (Right to buy)
May 03, 2023 Buy 3 534 Russell Angus C. Common Stock
May 03, 2023 Buy 5 915 Russell Angus C. Stock Option (Right to buy)
May 03, 2023 Buy 589 Coric Vlad Common Stock
May 03, 2023 Buy 986 Coric Vlad Stock Option (Right to buy)
May 03, 2023 Buy 3 534 Beraud Jill Common Stock
May 03, 2023 Buy 5 915 Beraud Jill Stock Option (Right to buy)
May 01, 2023 Sell 3 201 Schilke Tobin Common Stock
Apr 03, 2023 Sell 3 201 Schilke Tobin Common Stock
Mar 15, 2023 Sell 5 341 Foley Mark J Common Stock
Mar 15, 2023 Sell 3 739 Schilke Tobin Common Stock
Mar 15, 2023 Sell 7 330 Moxie Dwight Common Stock
Mar 15, 2023 Sell 2 967 Sjuts Dustin S Common Stock
Mar 09, 2023 Sell 18 496 Moxie Dwight Common Stock
Mar 09, 2023 Sell 18 517 Schilke Tobin Common Stock
Mar 09, 2023 Sell 21 508 Sjuts Dustin S Common Stock
Sep 22, 2022 Buy 42 349 Moxie Dwight Common Stock
Sep 22, 2022 Buy 42 349 Schilke Tobin Common Stock
Sep 22, 2022 Buy 52 396 Sjuts Dustin S Common Stock
Sep 22, 2022 Buy 175 649 Foley Mark J Common Stock
Feb 02, 2022 Buy 42 349 Moxie Dwight Common Stock
Feb 02, 2022 Buy 42 349 Schilke Tobin Common Stock
Feb 02, 2022 Buy 175 649 Foley Mark J Common Stock
Feb 02, 2022 Buy 52 395 Sjuts Dustin S Common Stock
JSON CSV
INSIDER POWER
106.985
Last 100 transactions
Buy: 3 127 708 | Sell: 494 320 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 106.985.

In total, the insiders bought 3 127 708 and sold 494 320 RVNC shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Revance Therapeutics

Revance Therapeutics Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to tre... RVNC Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT